European Companies Search Engine
EU funding (€9,592,029): COVID-19 infections - Remote Early Detection Hor 1 Jul 2020 EU Research and Innovation programme "Horizon"
Overview
Text
COVID-19 infections - Remote Early Detection
In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms. A prospective, observational study will follow 13,000 individuals from the general population and 7,000 high-risk individuals wearing the device and responding to participant self-report parameters via a purpose-designed app. Based on this data, an algorithm will indicate which individuals likely require general practitioner (GP) care (for COVID-19 diagnostic testing, further vital signs assessment, and/or treatment) and/or hospital care. To evaluate algorithm performance, the cohort will be tested for COVID-19 antibodies at the end of follow-up. COVID-19 seropositivity in the intervention cohort will be compared seropositivity in a control population of 20,000 individuals drawn from the same populations using the application only. Thus, this project will deliver a large body of information on COVID-19 PCR testing and antibodies that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.
Funded Companies:
| Company name | Funding amount |
| Ava AG | €0.00 |
| Ava Sciences FMTC GmbH | €3,774,250 |
| Julius Clinical Research B.V. | €2,026,248 |
| Labormedizinisches Zentrum DR Rischservices AG | €0.00 |
| Labormedizinosches Zentrum DR Rischostschweiz AG | €587,500 |
| Roche Diagnostics Nederland B.V. | €0.00 |
| Stichting Sanquin Bloedvoorziening | €1,350,000 |
| Takeda Pharmaceuticals International AG | €0.00 |
| Universitair Medisch Centrum Utrecht | €1,240,003 |
| University College London | €490,354 |
| Vive - DET Nationale Forsknings- og Analysecenter FOR Velfaerd | €123,675 |
Source: https://cordis.europa.eu/project/id/101005177
The filing refers to a past date, and does not necessarily reflect the current state.
